Search research articles
Contact Us
Filters
Showing results (481-490 of 580) with videos related to
Page
of 58
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 7, 2012
Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses
Germain J P Fernando, Xianfeng Chen, Clare A Primiero, et al.
International Immunology
|
October 7, 2004
Bypassing luminal barriers, delivery to a gut addressin by parenteral targeting elicits local IgA responses
Brent S McKenzie, Alexandra J Corbett, Susan Johnson, et al.
Frontiers in Immunology
|
September 16, 2017
Shared and Distinct Phenotypes and Functions of Human CD161++ Vα7.2+ T Cell Subsets
Ayako Kurioka, Aminu S Jahun, Rachel F Hannaway, et al.
The American Journal of Medicine
|
November 1, 1982
Myocardial rupture after myocardial infarction. Detection by multi-gated image-acquisition scintigraphy
P Nicod, J Corbett, R Leachman, et al.
The Journal of Biological Chemistry
|
October 16, 2015
Recognition of Vitamin B Precursors and Byproducts by Mucosal Associated Invariant T Cells
Sidonia B G Eckle, Alexandra J Corbett, Andrew N Keller, et al.
ACS Omega
|
June 15, 2026
Utility and Limitations of the Methyl Diaminobenzene-BODIPY Fluorescent Biosensor for Detecting Methylglyoxal in Cells
Rangsima Ponvattanaporn, Jeremy P Le, Zhimo Li, et al.
The American Journal of Cardiology
|
June 30, 2007
Late restenosis following sirolimus-eluting stent implantation
John Cosgrave, Simon J Corbett, Gloria Melzi, et al.
JAMA Neurology
|
April 24, 2014
The idiopathic intracranial hypertension treatment trial: clinical profile at baseline
Michael Wall, Mark J Kupersmith, Karl D Kieburtz, et al.
JAMA
|
April 24, 2014
Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial
, Michael Wall, Michael P McDermott, et al.
Immunology and Cell Biology
|
July 20, 2019
Chronically stimulated human MAIT cells are unexpectedly potent IL-13 producers
Jason Kelly, Yosuke Minoda, Tobias Meredith, et al.
Page
of 58
Search research articles
Search
Showing results (481-490 of 580) with videos related to
Sort By:
Page
of 58
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 7, 2012
Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses
Germain J P Fernando, Xianfeng Chen, Clare A Primiero, et al.
International Immunology
|
October 7, 2004
Bypassing luminal barriers, delivery to a gut addressin by parenteral targeting elicits local IgA responses
Brent S McKenzie, Alexandra J Corbett, Susan Johnson, et al.
Frontiers in Immunology
|
September 16, 2017
Shared and Distinct Phenotypes and Functions of Human CD161++ Vα7.2+ T Cell Subsets
Ayako Kurioka, Aminu S Jahun, Rachel F Hannaway, et al.
The American Journal of Medicine
|
November 1, 1982
Myocardial rupture after myocardial infarction. Detection by multi-gated image-acquisition scintigraphy
P Nicod, J Corbett, R Leachman, et al.
The Journal of Biological Chemistry
|
October 16, 2015
Recognition of Vitamin B Precursors and Byproducts by Mucosal Associated Invariant T Cells
Sidonia B G Eckle, Alexandra J Corbett, Andrew N Keller, et al.
ACS Omega
|
June 15, 2026
Utility and Limitations of the Methyl Diaminobenzene-BODIPY Fluorescent Biosensor for Detecting Methylglyoxal in Cells
Rangsima Ponvattanaporn, Jeremy P Le, Zhimo Li, et al.
The American Journal of Cardiology
|
June 30, 2007
Late restenosis following sirolimus-eluting stent implantation
John Cosgrave, Simon J Corbett, Gloria Melzi, et al.
JAMA Neurology
|
April 24, 2014
The idiopathic intracranial hypertension treatment trial: clinical profile at baseline
Michael Wall, Mark J Kupersmith, Karl D Kieburtz, et al.
JAMA
|
April 24, 2014
Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial
, Michael Wall, Michael P McDermott, et al.
Immunology and Cell Biology
|
July 20, 2019
Chronically stimulated human MAIT cells are unexpectedly potent IL-13 producers
Jason Kelly, Yosuke Minoda, Tobias Meredith, et al.
Page
of 58